Decongestant effects on hemodynamics at rest, exercise, and recovery from exercise during -6°of head down tilt

Aviation Space and Environmental Medicine

Volumn 70, Issue 1, 1999, Pages 15-21

  Rosene, John M ^a   Rosene, Jennifer A ^b   Koczajowski, Donna L ^c   Paolone, Vincent J ^d  

^a UNIVERSITY OF SOUTHERN MAINE   (United States)

^b MAINE MEDICAL CENTER   (United States)

^c U S COAST GUARD ACADEMY   (United States)

^d SPRINGFIELD COLLEGE   (United States)

Author keywords

Decongestant; Exercise; Hemodynamics; Microgravity

Indexed keywords

DECONGESTIVE AGENT; PLACEBO; PSEUDOEPHEDRINE;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; EXERCISE; FOREARM BLOOD FLOW; HEAD TILTING; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; MICROGRAVITY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PULSE PRESSURE; REST; VASCULAR RESISTANCE;

ADULT; DOUBLE-BLIND METHOD; EPHEDRINE; EXERCISE; EXERCISE TEST; HEAD-DOWN TILT; HEMODYNAMIC PROCESSES; HUMANS; MALE; REST; TIME FACTORS; VASOCONSTRICTOR AGENTS; WEIGHTLESSNESS SIMULATION;

EID: 0032924328     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Boren HG, Kory RC, Snyr JC. The veterans administration-army cooperative study of pulmonary function. Am J Med 1966; 41:96-114.
2. Charles JB, Lathers CM. Cardiovascular adaptation to spaceflight. J Clin Pharmacol 1991; 31:1010-23.
3. Coates ML, Rembold CM, Farr BM. Does pseudoephedrine increase blood pressure in patients with controlled hypertension? J Fam Pract 1995; 40:22-6.
4. 2max. Aviat Space Environ Med 1984; 55:702-8.
5. Derendorf H. Pharmacokinetic/pharmacodynamic consequences of space flight. J Clin Pharmacol 1994; 34:684-91.
6. Hargens AR, Tipton CM, Gollnick PD, et al. Fluid shifts and muscle function in humans during acute simulated weightlessness. J Appl Physiol 1983; 54:1003-9.
7. Hargens AR, Watenpaugh DE. Cardiovascular adaptation to spaceflight. Med Sci Sports Exerc 1996; 28:977-82.
8. Jernerus R, Lundin G, Thomson D. Cardiac output in healthy subjects determined with a CO2 rebreathing method. Acta Physiol Scand 1963; 59:390-9.
9. Kanfer I, Dowse R, Vuma V. Pharmacokinetics of oral decongestants. Pharmacotherapy 1993; 13:116S-28S.
10. Lathers CM, Charles JB, Elton KF, et al. Acute hemodynamic responses to weightlessness in humans. J Clin Pharmacol 1989; 29:615-27.
11. Lathers CM, Diamandis PH, Riddle JM, et al. Acute and intermediate cardiovascular responses to zero gravity and to fractional gravity levels induced by head-down or head-up tilt. J Clin Pharmacol 1990; 30:494-523.
12. Leach CS, Cintron NM, Krauhs JM. Metabolic changes observed in astronauts. J Clin Pharmacol 1991; 31:921-27.
13. Lollgen H, Gebhardt U, Beier J, et al. Central hemodynamics during zero gravity simulated by head-down bedrest. Aviat Space Environ Med 1984; 55:887-92.
14. Marcus RR, Horvath SM. Automated limb blood flow plethysmograph. Am J Physiol 1983; 244:H413-H416.
15. McEvoy GK, Litvak K, Welsh OH, et al., eds. AHFS drug information. Bethesda, MD: American Society of Hospital Pharmacists, 1992.
16. Nicogossian AE, Huntoon CL, Pool SL. Space physiology and medicine, 3rd ed. Philadelphia, PA: Lea & Febiger, 1994.
17. Smith MB, Feldman W. Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991. JAMA 1993; 269:2258-63.
18. Tomaselli CM, Kenney RA, Frey MAB, Hoffler GW. Cardiovascular dynamics during the initial period of head-down tilt. Aviat Space Environ Med 1987; 58:3-8.